![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
1 Laboratory of Chemistry, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Maryland, and Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston University Medical Center, Boston, Massachusetts
The development and loss of tolerance in the rat to the effects of morphine on two measures of response, reaction to a noxious stimulus (heat)and speed of swimming, were studied. Tolerance to the drug effect developed in a parallel fashion for both measures. Return of drug sensitivity, however, was much more rapid with swimming than with the response to heat. The degree of tolerance achieved, as measured by the hot plate, was the same when animals were given 100 mg/kg of morphine sulfate twice daily for 50 days or 20 mg/kg seven times at irregular intervals. This effect of a relatively few irregularly spaced injections in producing a profound degree of tolerance was not seen when speed of swimming was used as a measure of response to drug. Complete recovery of drug sensitivity after a course of chronic morphine administration does not occur for at least 9 months as measured by swimming and more than 12 months as tested by the hot plate. The effects of a single injection of 20 mg/kg of morphine sulfate can be observed for at least a year using the hot plate as a test of drug response. No effects of a single previous injection of morphine sulfate can be detected using speed of swimming as the response measured.
Accepted on April 3, 1964
This article has been cited by other articles:
|
|
 |
|
  A. R. Gintzler and S. Chakrabarti The Ambiguities of Opioid Tolerance Mechanisms: Barriers to Pain Therapeutics or New Pain Therapeutic Possibilities J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 709 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Govitrapong, T. Suttitum, N. Kotchabhakdi, and T. Uneklabh Alterations of Immune Functions in Heroin Addicts and Heroin Withdrawal Subjects J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 883 - 889. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Lange, S. Roerig, J. Fujimoto, and R. Wang Absence of cross-tolerance to heroin in morphine-tolerant mice Science, April 4, 1980; 208(4439): 72 - 74. [Abstract] [PDF]
|
|
|
|
|
|
R. Kesner, D. Priano, and DeWitt JR Time-dependent disruption of morphine tolerance by electroconvulsive shock and frontal cortical stimulation Science, December 3, 1976; 194(4269): 1079 - 1081. [Abstract] [PDF]
|
|
|
|
|
|
G. Friedler and J. Cochin Growth Retardation in Offspring of Female Rats Treated with Morphine Prior to Conception Science, February 11, 1972; 175(4022): 654 - 656. [Abstract] [PDF]
|
|
|
|
|
|
S. R. Goldberg and C. R. Schuster Nalorphine: increased sensitivity of monkeys formerly dependent on morphine. Science, December 19, 1969; 166(3912): 1548 - 1549. [Abstract] [PDF]
|
|
|
|
|
|
C. Kornetsky and G. Bain Morphine: Single-Dose Tolerance Science, November 29, 1968; 162(3857): 1011 - 1012. [Abstract] [PDF]
|
|
|
|
|
|
J. R. Nichols and S. Hsiao Addiction Liability of Albino Rats: Breeding for Quantitative Differences in Morphine Drinking Science, August 4, 1967; 157(3788): 561 - 563. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
